Bank of New York Mellon
ARTV

Bank of New York Mellon’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bank of New York Mellon’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,305
Closed -$99.9K – 4275
2025
Q1 		$99.9K Hold
33,305
– – ﹤0.01% 3983
2024
Q4 		$336K Buy
33,305
+2,096
+7% +$21.1K ﹤0.01% 3698
2024
Q3 		$482K Buy
+31,209
New +$482K ﹤0.01% 3531